Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Agema BC"'
Autor:
Agema BC; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands. Electronic address: b.agema@erasmusmc.nl., Berrich M; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands., Seuren L; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands., Sassen SDT; Dept. of Clinical Pharmacy, Erasmus MC, Rotterdam, the Netherlands., Miedema JR; Dept. of Pulmonology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands., Koch BCP; Dept. of Clinical Pharmacy, Erasmus MC, Rotterdam, the Netherlands., Wijsenbeek MS; Dept. of Pulmonology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands., Koolen SLW; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands; Dept. of Clinical Pharmacy, Erasmus MC, Rotterdam, the Netherlands., Mathijssen RHJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands., Veerman GDM; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands; Dept. of Pulmonology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Oct; Vol. 179, pp. 117341. Date of Electronic Publication: 2024 Aug 26.
Autor:
Agema BC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Kocher T; Department of Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Öztürk AB; Department of Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Giraud EL; Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands., van Erp NP; Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands., de Winter BCM; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Koch BCP; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Sassen SDT; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands. s.sassen@erasmusmc.nl.; Department of Hospital Pharmacy, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. s.sassen@erasmusmc.nl.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.
Autor:
Agema BC; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Clinical Pharmacy (B.C.P.K., S.L.W.K.), Erasmus MC University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group (B.C.P.K.), Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: b.agema@erasmusmc.nl., Vrielink K; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Tienen F; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Geijteman ECT; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Van der Rijt CCD; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Koch BCP; Department of Clinical Pharmacy (B.C.P.K., S.L.W.K.), Erasmus MC University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group (B.C.P.K.), Erasmus University Medical Center, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Clinical Pharmacy (B.C.P.K., S.L.W.K.), Erasmus MC University Medical Center, Rotterdam, The Netherlands., Oosten AW; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology (B.C.A., K.V., E.O.D.H., F.V.T., E.G., C.C.D.V.D.R., S.L.W.K., A.W.O., R.H.J.M.), Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Journal of pain and symptom management [J Pain Symptom Manage] 2024 Aug 29. Date of Electronic Publication: 2024 Aug 29.
Autor:
Agema BC; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: b.agema@erasmusmc.nl., Buck SAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Viskil M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Isebia KT; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., de Neijs MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Sassen SDT; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Koch BCP; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Joerger M; Department of Medical Oncology and Hematology, Cantonal Hospital, St. Gallen, Switzerland., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 786-793. Date of Electronic Publication: 2023 Nov 03.
Autor:
Agema BC; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center; Rotterdam, the Netherlands; Dept. of Clinical Pharmacy, Erasmus University Medical Center; Rotterdam, the Netherlands. Electronic address: b.agema@erasmusmc.nl., Buijs SM; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center; Rotterdam, the Netherlands., Sassen SDT; Dept. of Clinical Pharmacy, Erasmus University Medical Center; Rotterdam, the Netherlands; Rotterdam Clinical Pharmacometrics Group; Rotterdam, the Netherlands., Mürdter TE; Margarete Fischer-Bosch-Institute of Clinical Pharmacology; Stuttgart, Germany; University of Tübingen; Tübingen, Germany., Schwab M; Margarete Fischer-Bosch-Institute of Clinical Pharmacology; Stuttgart, Germany; Dept. of Clinical Pharmacology, University Hospital Tübingen; Tübingen, Germany; iFIT Cluster of Excellence (EXC2180) 'Image Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Koch BCP; Dept. of Clinical Pharmacy, Erasmus University Medical Center; Rotterdam, the Netherlands; Rotterdam Clinical Pharmacometrics Group; Rotterdam, the Netherlands., Jager A; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center; Rotterdam, the Netherlands., van Schaik RHN; Dept. of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands., Mathijssen RHJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center; Rotterdam, the Netherlands., Koolen SLW; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center; Rotterdam, the Netherlands; Dept. of Clinical Pharmacy, Erasmus University Medical Center; Rotterdam, the Netherlands.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Apr; Vol. 160, pp. 114369. Date of Electronic Publication: 2023 Feb 06.
Autor:
Agema BC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam 3015 GD, The Netherlands Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Veerman GDM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Steendam CMJ; Department of Pulmonology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Lanser DAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Preijers T; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Leest C; Department of Pulmonology, Amphia Hospital, Breda, The Netherlands., Koch BCP; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Dingemans AC; Department of Pulmonology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Jun 03; Vol. 14, pp. 17588359221103212. Date of Electronic Publication: 2022 Jun 03 (Print Publication: 2022).
Autor:
Agema BC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands.; Department of Clinical Pharmacy, Erasmus University Medical Center, dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands., Sassen SDT; Department of Clinical Pharmacy, Erasmus University Medical Center, dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands., Rietdijk WJR; Department of Clinical Pharmacy, Erasmus University Medical Center, dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands., van der Rijt CCD; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands., Koch BCP; Department of Clinical Pharmacy, Erasmus University Medical Center, dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands.; Department of Clinical Pharmacy, Erasmus University Medical Center, dr. Molewaterplein 40, 3015GD Rotterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Jun 02; Vol. 13 (11). Date of Electronic Publication: 2021 Jun 02.
Autor:
Agema BC; Department of Clinical Chemistry, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Clinical Pharmacy, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., With M; Department of Clinical Chemistry, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Doorn NV; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Heersche N; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Hoop EO; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Visser S; Department of Pulmonology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Pulmonology, Amphia Hospital, 4818 CK Breda, The Netherlands., Aerts JGJV; Department of Pulmonology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Pulmonology, Amphia Hospital, 4818 CK Breda, The Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Schaik RHNV; Department of Clinical Chemistry, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Publikováno v:
Genes [Genes (Basel)] 2020 Mar 27; Vol. 11 (4). Date of Electronic Publication: 2020 Mar 27.
Autor:
Belderbos BPS; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., de With M; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Singh RK; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Agema BC; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., El Bouazzaoui S; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. s.bins@erasmusmc.nl.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Mar; Vol. 85 (3), pp. 547-553. Date of Electronic Publication: 2020 Jan 01.
Autor:
Goey AK; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., With M; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands., Agema BC; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands., Hoop EO; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Singh RK; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., van der Veldt AA; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., van Schaik RH; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands., Bins S; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Pharmacogenomics [Pharmacogenomics] 2019 Dec; Vol. 20 (18), pp. 1283-1290.